Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05816239 · ClinicalTrials.gov registry record
LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study
A clinical trial of Lung Perfusion, sponsored by Sameer Avasarala.
- Completed
- Registry status
- 13
- Enrollment target
- 1
- Study location
NCT05816239 is a study of Lung Perfusion that has completed, run by Sameer Avasarala. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05816239, a study of Lung Perfusion, has completed, sponsored by Sameer Avasarala.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to see if a special CT scan (dual-energy CT) provides useful information in patients undergoing bronchsoscopic lung volume reduction (valve placement for emphysema). The investigators will enroll up to 30 participants in this study from University Hospitals Cleveland Medical Center. All of the participants from this study will undergo their valve procedure at University Hospitals Cleveland Medical Center.
Conditions Studied
Interventions
- PROCEDURE Dual Energy CT
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-02-24 |
| Est. Completion | 2025-05-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05816239
The ClinicalTrials.gov registry entry for NCT05816239 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sameer Avasarala, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Perfusion appearing as the primary indexed condition, and to 1 intervention - of which Dual Energy CT is the first listed.
NCT05816239 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05816239 about?
NCT05816239 is a clinical study titled "LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study". The purpose of this research study is to see if a special CT scan (dual-energy CT) provides useful information in patients undergoing bronchsoscopic lung volume reduction (valve placement for emphysema). The investigators will enroll up to 30 participants in this study from University Hospitals Clev...
What is the current status of trial NCT05816239?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2023-02-24. Estimated completion is 2025-05-24.
What conditions does trial NCT05816239 study?
This clinical trial studies the following conditions: Lung Perfusion.
What interventions are being tested in trial NCT05816239?
The interventions under investigation include: Dual Energy CT (PROCEDURE).
Who is sponsoring clinical trial NCT05816239?
This trial is sponsored by Sameer Avasarala, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05816239 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.